SUBSCRIBE
SUBSCRIBE
News   Business

Repros Therapeutics Inc. Reports First Quarter 2008 Financial Results and Provides Clinical Development Program Overview

May 12, 2008 | 
1 min read

THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM:RPRX) today announces financial results for the first quarter ended March 31, 2008 and provides a clinical development program overview.

Earnings
MORE ON THIS TOPIC
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
November 22, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & Acquisitions
Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science
November 21, 2024
 · 
2 min read
 · 
Annalee Armstrong
Business
51%: The Untapped Market
November 21, 2024
 · 
1 min read
 · 
Lori Ellis
Novartis' office building in Marburg, Germany
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac